Wei Ling
Peking Union Medical College
9 Papers
18 Citations
Wei Ling is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Hematopoietic stem cell transplantation & Graft-versus-host disease. The author has an hindex of 4, co-authored 9 publications. Previous affiliations of Wei Ling include Guangdong General Hospital.
Chat about Author
Papers
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.
Jianyu Weng,Jianyu Weng,Xin Du,Xin Du,Suxia Geng,Suxia Geng,Yanwen Peng,Zhen Wang,Z S Lu,Z S Lu,Suijing Wu,Suijing Wu,Chenwei Luo,Chenwei Luo,R Guo,R Guo,Wei Ling,Wei Ling,Chenxin Deng,Chenxin Deng,Pengjun Liao,Pengjun Liao,Andy Peng Xiang +22 more
TL;DR: Transfusion of MSCs expanded in vitro, irrespective of the donor, might be a safe and effective salvage therapy for patients with steroid-resistant, cGVHD.
Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response
Liyan Guo,Peilong Lai,Yulian Wang,Tian Huang,Tian Huang,Xiaomei Chen,Suxia Geng,Xin Huang,Chenwei Luo,Suijing Wu,Wei Ling,Lisi Huang,Xin Du,Weng Jianyu +13 more
TL;DR: MSC-EVs prevent the fibrosis of sclerodermatous cGVHD mouse model by suppressing the activation of macrophages and B cells immune response.
40
Gene Expression Profiling-Based Identification of CD28 and PI3K as New Biomarkers for Chronic Graft-Versus-Host Disease
Peilong Lai,Jianyu Weng,Zesheng Lu,Rong Guo,Chenwei Luo,Suijing Wu,Wei Ling,Suxia Geng,Xin Du +8 more
TL;DR: It is suggested that the upregulation of CD28 and PI3K contributed to the onset and progression of cGVHD and provided evidence thatCD28 andPI3K may serve as promising biomarkers for cGV HD.
12
von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy:
Zhenzhen Xu,Chengwei Luo,Peilong Lai,Wei Ling,Suijing Wu,Xin Huang,Lisi Huang,Guanrong Zhang,Xin Du,Jianyu Weng +9 more
TL;DR: Von Willebrand factor is a useful predictor and prognostic measure for TA-TMA, which may help clinicians identify and manage this life-threatening disease earlier.
10
•Journal Article
Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.
Kexin Ai,Minming Li,Ping Wu,Chengxin Deng,Xin Huang,Wei Ling,Ruohao Xu,Suxia Geng,Qihui Sun,Jianyu Weng,Xin Du,Xin Du +11 more
TL;DR: The concurrence of myelodysplastic syndromes (MDS) and large granular lymphocyte leukemia (LGLL) has been reported in a small group of patients and might suggest an etiologic relationship rather than a simple coincidence as mentioned in this paper.
6